共 13 条
- [1] Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B-cell lymphoma: a phase I study by the Fondazione Italiana Linfomi[J]. HAEMATOLOGICA, 2013, 98 (11) : 1732 - 1738Chiappella, AnnalisaTucci, AlessandraCastellino, AlessiaPavone, VincenzoBaldi, IleanaCarella, Angelo MicheleOrsucci, LorellaZanni, ManuelaSalvi, FlaviaLiberati, Anna MarinaGaidano, GianlucaBottelli, ChiaraRossini, BernardoPerticone, SoniaDe Masi, PasqualinaLadetto, MarcoCiccone, GiovanninoPalumbo, AntonioRossi, GiuseppeVitolo, Umberto
- [2] CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (04) : 235 - 242Coiffier, BLepage, EBrière, JHerbrecht, RTilly, HBouabdallah, RMorel, PVan den Neste, ESalles, GGaulard, PReyes, FGisselbrecht, C
- [3] Randomized Trial Comparing R-CHOP Versus High-Dose Sequential Chemotherapy in High-Risk Patients With Diffuse Large B-Cell Lymphomas[J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (33) : 4015 - U128Cortelazzo, SergioTarella, CorradoGianni, Alessandro MassimoLadetto, MarcoBarbui, Anna MariaRossi, AndreaGritti, GiuseppeCorradini, PaoloDi Nicola, MassimoPatti, CaterinaMule, AntoninoZanni, ManuelaZoli, ValerioBillio, AttoPiccin, AndreaNegri, GiovanniCastellino, ClaudiaDi Raimondo, FrancescoFerreri, Andres J. M.Benedetti, FabioLa Nasa, GiorgioGini, GuidoTrentin, LivioFrezzato, MaurizioFlenghi, LeonardoFalorio, SimonaChilosi, MarcoBruna, RiccardoTabanelli, ValentinaPileri, StefanoMasciulli, AriannaDelaini, FedericaBoschini, CristinaRambaldi, Alessandro
- [4] Randomized, Double-Blind, Phase III Trial of Enzastaurin Versus Placebo in Patients Achieving Remission After First-Line Therapy for High-Risk Diffuse Large B-Cell Lymphoma[J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (21) : 2484 - +Crump, MichaelLeppa, SirpaFayad, LuisLee, Je JungDi Rocco, AliceOgura, MichinoriHagberg, HansSchnell, FrederickRifkin, RobertMackensen, AndreasOffner, FritzPinter-Brown, LaurenSmith, SonaliTobinai, KenseiYeh, Su-PengHsi, Eric D.Tuan NguyenShi, PeipeiHahka-Kemppinen, MarjoThornton, DonLin, BorisKahl, BradSchmitz, NorbertSavage, Kerry J.Habermann, Thomas
- [5] Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma[J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (19) : 3121 - 3127Habermann, Thomas M.Weller, Edie A.Morrison, Vicki A.Gascoyne, Randy D.Cassileth, Peter A.Cohn, Jeffrey B.Dakhil, Shaker R.Woda, BruceFisher, Richard I.Peterson, Bruce A.Horning, Sandra J.
- [6] Nowakowski G, 2016, BLOOD, V128
- [7] Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: phase I study[J]. LEUKEMIA, 2011, 25 (12) : 1877 - 1881Nowakowski, G. S.LaPlant, B.Habermann, T. M.Rivera, C. E.Macon, W. R.Inwards, D. J.Micallef, I. N.Johnston, P. B.Porrata, L. F.Ansell, S. M.Klebig, R. R.Reeder, C. B.Witzig, T. E.
- [8] Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone[J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (22) : 2473 - +Thieblemont, CatherineTilly, Herveda Silva, Maria GomesCasasnovas, Rene-OlivierFruchart, ChristopheMorschhauser, FranckHaioun, CorinneLazarovici, JulienGrosicka, AnidaPerrot, AuroreTrotman, JudithSebban, CatherineCaballero, DoloresGreil, Richardvan Eygen, KoenCohen, Amos M.Gonzalez, HugoBouabdallah, RedaOberic, LucieCorront, BernadetteChoufi, BachraLopez-Guillermo, ArmandoCatalano, JohnVan Hoof, AchielBriere, JosetteCabeOadas, JoseSalles, GillesGaulard, PhilippeBosly, AndreCoiffier, Bertrand
- [9] Obinutuzumab or Rituximab Plus CHOP in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma: Final Results from an Open-Label, Randomized Phase 3 Study (GOYA)[J]. BLOOD, 2016, 128 (22)Vitolo, UmbertoTrneny, MarekBelada, DavidCarella, Angelo M.Chua, NeilAbrisqueta, PauDemeter, JuditFlinn, Ian W.Hong, XiaonanKim, Won SeogPinto, AntonioBurke, John M.Shi, YuankaiTatsumi, YoichiOestergaard, MikkelWenger, Michael K.Fingerle-Rowson, GunterCatalani, OlivierNielsen, TinaMartelli, MaurizioSehn, Laurie H.
- [10] Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial[J]. LANCET ONCOLOGY, 2014, 15 (07) : 730 - 737Vitolo, UmbertoChiappella, AnnalisaFranceschetti, SilviaCarella, Angelo MicheleBaldi, IleanaInghirami, GiorgioSpina, MichelePavone, VincenzoLadetto, MarcoLiberati, Anna MarinaMolinari, Anna LiaZinzani, PierluigiSalvi, FlaviaFattori, Pier PaoloZaccaria, AlfonsoDreyling, MartinBotto, BarbaraCastellino, AlessiaCongiu, AngelaGaudiano, MarcelloZanni, ManuelaCiccone, GiovanninoGaidano, GianlucaRossi, Giuseppe